IDiyas

For the Inventor, By the Inventor

Nagoya, Japan

Masami Nakane

USPTO Granted Patents = 18

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 125(Granted Patents)


Location History:

  • Aichi, JP (1995 - 1996)
  • Showakyu, JP (1998 - 1999)
  • Nagoya, JP (1991 - 2000)
  • Showakyu, Nagoya 466, JP (2001)

Company Filing History:

goldMedal17 out of 4,455 
 
Pfizer Corporation
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1991-2001

Loading Chart...
18 patents (USPTO):Explore Patents
1. 6222038 - Quinuclidine derivatives (2001-04-24),
2. 6083943 - Substituted azaheterocyclecarboxylic acid (2000-07-04),
3. 5939433 - Quinuclidine derivatives (1999-08-17),
4. 5886009 - Quinuclidine derivative as a substance P antagonist (1999-03-23),
5. 5852038 - Substituted 3-aminoquinuclidines (1998-12-22),
6. 5837711 - Substituted quinuclidines as substance P antagonists (1998-11-17),
7. 5807867 - Quinuclidine derivatives (1998-09-15),
8. 5721255 - Substituted benzylamino nitrogen containing non-aromatic heterocycles (1998-02-24),
9. 5716965 - Substituted 3-aminoquinuclidines (1998-02-10),
10. 5681858 - Cycloalkyl hydroxyureas (1997-10-28),
11. 5569662 - Quinuclidine derivatives as substance P antagonists (1996-10-29),
12. 5504095 - Aminobenzosultam derivatives as lipoxygenase inhibitors (1996-04-02),
13. 5464849 - N-hydroxyurea derivatives as antiallergy and antiinflammatory agents (1995-11-07),
14. 5290788 - Indole derivatives as antiallergy and antiinflammatory agents (1994-03-01),
15. 5256789 - Antiinflammatory hydroxamic acids and N-hydroxyureas (1993-10-26),

Title: Masami Nakane: Innovator in Pharmaceutical Chemistry

Introduction

Masami Nakane is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 18 patents to his name, Nakane's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Nakane has developed quinuclidine derivatives and substituted azaheterocyclecarboxylic acids. These compounds exhibit excellent substance P antagonistic activity, making them useful for treating various conditions such as gastrointestinal disorders, central nervous system disorders, allergies, inflammatory diseases, asthma, pain, emesis, and migraines in mammals, especially humans. Notable examples of his patented compounds include (2S*,3S*,4R*,5R*)-4-Carboxy-3-[N-(5-Isopropyl-2-methoxy-benzyl)amino]-5-methyl-2-phenylpyrrolidine and (2S*,3S*,5S*)-5-Carboxy-3-[N-(2-methoxy-5-trifluoromethoxybenzyl)amino]-2-phenylpiperidine.

Career Highlights

Throughout his career, Nakane has worked with leading pharmaceutical companies, including Pfizer Corporation. His innovative research has led to advancements in drug development and therapeutic solutions.

Collaborations

Masami Nakane has collaborated with notable colleagues such as Fumitaka Ito and Kunio Satake. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Masami Nakane's contributions to the field of pharmaceutical chemistry are noteworthy, with a focus on developing innovative compounds for medical treatment. His work continues to influence the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…